Physician profile
Kiley Ferer
NPI 1043927270
$9,169.00
in general payments reported to CMS, 2019-2025
34 companies · $2,967 in 2025
The $2,967 reported for 2025 was more than what 97% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $42.33 · 2023: $2,747 · 2024: $3,413 · 2025: $2,967.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $9,115 · Education: $11.71.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $9,114.96 |
| Education | $11.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $1,470.79 | 2023-2025 | Farxiga, Breztri, Airsupra |
| Abbvie INC. | $1,439.85 | 2023-2025 | |
| Novo Nordisk INC | $1,224.79 | 2022-2025 | Ozempic, Rybelsus, Wegovy |
| Boehringer Ingelheim Pharmaceuticals, INC. | $823.49 | 2023-2025 | Jardiance, Tradjenta, Spiriva Respimat |
| Lilly USA, LLC | $767.01 | 2023-2025 | Mounjaro, Jardiance, Zepbound |
| Pfizer INC. | $681.18 | 2023-2025 | |
| Glaxosmithkline, LLC. | $382.68 | 2023-2025 | Arexvy, Shingrix, Trelegy Ellipta |
| Merck Sharp & Dohme LLC | $317.45 | 2023-2025 | Gardasil 9, Capvaxive, Vaxelis |
| Bayer Healthcare Pharmaceuticals INC. | $300.42 | 2023-2025 | |
| Amgen INC. | $256.57 | 2023-2025 | Repatha, Otezla, Repatha |
| Otsuka America Pharmaceutical, INC. | $235.20 | 2023-2025 | Rexulti, Nuedexta |
| Exact Sciences Corporation | $211.22 | 2023-2025 | Cologuard Collection Kit |
| Astellas Pharma US INC | $209.78 | 2024-2025 | Veozah |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $154.16 | 2022-2025 | Xifaxan, Cycloset |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $112.87 | 2025 | Caplyta |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $77.56 | 2025 | Freestyle Libre 3 |
| Sumitomo Pharma America, INC. | $59.93 | 2023-2025 | Gemtesa |
| Sanofi Pasteur INC. | $59.02 | 2023-2024 | |
| Renalytix Ai, INC. | $37.04 | 2023 | Kidneyintelx Blood Collection Convenience Kit |
| Seqirus USA INC | $35.15 | 2023-2024 | Fluad Quadrivalent, Flucelvax Quadrivalent, Fluad |
| Dexcom, INC. | $34.34 | 2024 | Dexcom G6 Transmitter |
| Takeda Pharmaceuticals U.S.A., INC. | $28.63 | 2023 | Trintellix |
| Alkermes, INC. | $28.25 | 2024 | Vivitrol |
| Amphastar Pharmaceuticals, INC. | $27.96 | 2025 | |
| Kowa Pharmaceuticals America, INC. | $27.38 | 2025 | Zoryve |
| Lundbeck LLC | $25.57 | 2025 | Rexulti |
| Eisai INC. | $22.56 | 2024 | |
| Phadia US INC. | $19.55 | 2023 | Immunocap |
| Daiichi Sankyo INC. | $17.30 | 2023 | Injectafer |
| Alexion Pharmaceuticals, INC. | $17.13 | 2024 | Strensiq |
| Medtronic, INC. | $17.07 | 2025 | Venaseal |
| Xeris Pharmaceuticals, INC. | $16.79 | 2024 | Gvoke Hypopen |
| Verrica Pharmaceuticals INC. | $15.16 | 2024 | Ycanth |
| Biohaven Pharmaceutical Holding Company LTD. | $15.15 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kiley Ferer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.